Results 191 to 200 of about 14,184,553 (374)

Isolation and Properties of the Abnormal Factor IX Molecule of Hemophilia BM [PDF]

, 1977
Bjarne Østerud, K K Lavine, Carol K. Kasper, Samuel I. Rapaport   +3 more
openalex   +1 more source

Evaluation and failure analysis of four commercial deep learning‐based autosegmentation software for abdominal organs at risk

Journal of Applied Clinical Medical Physics, Volume 26, Issue 4, April 2025.
Abstract Purpose Deep learning‐based segmentation of organs‐at‐risk (OAR) is emerging to become mainstream in clinical practice because of the superior performance over atlas and model‐based autocontouring methods. While several commercial deep learning‐based autosegmentation solutions are now available, the implementation of these tools is still at ...
Mingdong Fan, Tonghe Wang, Yang Lei, Pretesh R. Patel, Sean Dresser, Beth Bradshaw Ghavidel, Richard L. J. Qiu, Jun Zhou, Kirk Luca, Oluwatosin Kayode, Jeffrey D. Bradley, Xiaofeng Yang, Justin Roper   +12 more
wiley   +1 more source

Extended Half-Life Factor VIII and Factor IX Preparations

Transfusion Medicine and Hemotherapy, 2018
L. Graf
semanticscholar   +1 more source

A Bypass Mechanism for Activating Human Factor IX with Human Factor VII and Thromboplastin [PDF]

, 1977
Bjarne Østerud, S.I. Rapaport
openalex   +1 more source

Assessing proton plans with three different beam delivery systems versus photon plans for head and neck tumors

Journal of Applied Clinical Medical Physics, Volume 26, Issue 5, May 2025.
Abstract Purpose To compare plan quality among photon volumetric modulated arc therapy (VMAT) and intensity‐modulated proton therapy (IMPT) with robustness using three different proton beam delivery systems with various spot size (σ) ranges: cyclotron‐generated proton beams (CPBs) (σ: 2.7–7.0 mm), linear accelerator proton beams (LPBs) (σ: 2.9–5.5 mm),
Tara Gray, Chieh‐Wen Liu, Saeed Ahmed, Anna Maria Kolano, Jeremy Donaghue, Shlomo Koyfman, Neil Woody, Shauna R. Campbell, Jonathan B. Farr, Ping Xia   +9 more
wiley   +1 more source

Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement Therapies

Seminars in Thrombosis and Hemostasis, 2017
S. Kitchen, S. Tiefenbacher, R. Gosselin
semanticscholar   +1 more source

Importancia del diagnóstico de portadoras en familias con antecedentes de hemofilia

Revista Cubana de Hematología, Inmunología y Hemoterapia
La hemofilia es una enfermedad hemorrágica hereditaria ligada al cromosoma X que se presenta debido a mutaciones en los genes del factor VIII (hemofilia A) y el factor IX (hemofilia B), que ocasiona una disminución o deficiencia funcional de estas ...
Kalia Lavaut Sánchez
doaj  

SPONTANEOUSLY ACQUIRED FACTOR IX INHIBITOR IN A NON-HEMOPHILIAC CHILD [PDF]

, 1977
Kenneth W. Miller, John E. Neely, William Krivit, J. Roger Edson   +3 more
openalex   +1 more source

The effect of kV imaging dose on PTV and OAR planning constraints in lung SBRT using stereoscopic/monoscopic real‐time tumor‐monitoring system

Journal of Applied Clinical Medical Physics, Volume 26, Issue 5, May 2025.
Abstract Purpose Quantify the impact of additional imaging doses on clinical dose constraints during lung stereotactic body radiotherapy (SBRT) treatment utilizing stereoscopic/monoscopic real‐time tumor monitoring. Materials and Methods Thirty lung SBRT patients treated with the volumetric arc therapy technique were randomly selected from the ...
Ruwan Abeywardhana, Mike Sattarivand
wiley   +1 more source

Systemic delivery of factor IX messenger RNA for protein replacement therapy

Proceedings of the National Academy of Sciences of the United States of America, 2017
Suvasini Ramaswamy, Nina Tonnu, K. Tachikawa, P. Limphong, J. Vega, P. Karmali, P. Chivukula, I. Verma   +7 more
semanticscholar   +1 more source